课题基金 / 基金详情

Defining New Human Immunodeficiency and Immunodysregulation Disorders

Defining New Human Immunodeficiency and Immunodysregulation Disorders
定义新的人类免疫缺陷和免疫失调疾病
批准号:
7732707
负责人:
Helen Su
金额:
$65.76万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Helen Su的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Besides unique patients with immunodeficiency and immunodysregulation disorders lacking known diagnoses, our intake includes patients with variants of autoimmune lymphoproliferative syndrome (ALPS) or caspase-8-deficiency state (CEDS), common variable immunodeficiency (CVID), X-linked lymphoproliferative syndrome (XLP), and Evans syndrome. We have evaluated 73 new patients and their relatives over the past year, for 200 cumulatively, using functional screening and gene sequencing to exclude known disease. About 20 are being more intensively studied using biochemical analyses and gene expression microarrays. These experiments have provided leads for sequencing of new candidate genes not previously associated with disease, which is currently in progress.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Host factors contributing to susceptibility to COVID-19 disease
Molecular Mechanisms of Familial Hemophagocytic Lymphohistiocytosis
Defining New Human Immunodeficiency and Immunodysregulation Disorders
Defining New Human Immunodeficiency and Immunodysregulation Disorders
海外基金